Inovalon Holdings, Inc. (NASDAQ:INOV) Receives $26.13 Consensus Price Target from Analysts
Inovalon Holdings, Inc. (NASDAQ:INOV) has received an average rating of “Hold” from the ten brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $26.13.
Several research firms have commented on INOV. Zacks Investment Research upgraded shares of Inovalon from a “sell” rating to a “hold” rating in a report on Wednesday. Morgan Stanley boosted their price target on shares of Inovalon from $23.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, February 4th. BTIG Research boosted their price target on shares of Inovalon from $25.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, January 12th. Piper Sandler boosted their price target on shares of Inovalon from $14.00 to $22.00 and gave the stock an “underweight” rating in a report on Thursday, February 4th. Finally, SVB Leerink boosted their price objective on shares of Inovalon from $27.00 to $31.00 and gave the stock an “outperform” rating in a research report on Thursday, February 4th.
In related news, insider Jason Capitel sold 20,000 shares of the stock in a transaction dated Thursday, April 1st. The shares were sold at an average price of $28.88, for a total value of $577,600.00. Also, Director Mark Pulido sold 100,000 shares of the stock in a transaction dated Friday, February 5th. The shares were sold at an average price of $26.39, for a total transaction of $2,639,000.00. Following the completion of the sale, the director now directly owns 254,760 shares in the company, valued at $6,723,116.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 120,996 shares of company stock worth $3,239,309. Corporate insiders own 49.59% of the company’s stock.
Shares of INOV stock opened at $29.95 on Monday. The company has a debt-to-equity ratio of 1.33, a current ratio of 1.95 and a quick ratio of 1.95. The firm’s 50-day moving average is $26.78 and its two-hundred day moving average is $23.72. Inovalon has a 12 month low of $15.15 and a 12 month high of $30.56. The company has a market capitalization of $4.65 billion, a PE ratio of 748.94, a price-to-earnings-growth ratio of 2.19 and a beta of 0.64.
Inovalon (NASDAQ:INOV) last announced its quarterly earnings results on Wednesday, February 3rd. The technology company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.05. The business had revenue of $189.40 million during the quarter, compared to analysts’ expectations of $187.44 million. Inovalon had a net margin of 0.87% and a return on equity of 9.07%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the business earned $0.15 earnings per share. Sell-side analysts forecast that Inovalon will post 0.45 EPS for the current year.
Inovalon Holdings, Inc provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights.
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.